Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting cancer with phosphodiesterase inhibitors.
Savai R, Pullamsetti SS, Banat GA, Weissmann N, Ghofrani HA, Grimminger F, Schermuly RT. Savai R, et al. Among authors: grimminger f. Expert Opin Investig Drugs. 2010 Jan;19(1):117-31. doi: 10.1517/13543780903485642. Expert Opin Investig Drugs. 2010. PMID: 20001559 Review.
cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.
Pullamsetti SS, Savai R, Schaefer MB, Wilhelm J, Ghofrani HA, Weissmann N, Schudt C, Fleming I, Mayer K, Leiper J, Seeger W, Grimminger F, Schermuly RT. Pullamsetti SS, et al. Among authors: grimminger f. Circulation. 2011 Mar 22;123(11):1194-204. doi: 10.1161/CIRCULATIONAHA.110.941484. Epub 2011 Mar 7. Circulation. 2011. PMID: 21382892
Riociguat for the treatment of pulmonary hypertension.
Schermuly RT, Janssen W, Weissmann N, Stasch JP, Grimminger F, Ghofrani HA. Schermuly RT, et al. Among authors: grimminger f. Expert Opin Investig Drugs. 2011 Apr;20(4):567-76. doi: 10.1517/13543784.2011.565048. Epub 2011 Mar 11. Expert Opin Investig Drugs. 2011. PMID: 21391889 Review.
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F. Ghofrani HA, et al. Among authors: grimminger f. J Am Coll Cardiol. 2004 Oct 6;44(7):1488-96. doi: 10.1016/j.jacc.2004.06.060. J Am Coll Cardiol. 2004. PMID: 15464333 Free article. Clinical Trial.
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT, Pullamsetti SS, Kwapiszewska G, Dumitrascu R, Tian X, Weissmann N, Ghofrani HA, Kaulen C, Dunkern T, Schudt C, Voswinckel R, Zhou J, Samidurai A, Klepetko W, Paddenberg R, Kummer W, Seeger W, Grimminger F. Schermuly RT, et al. Among authors: grimminger f. Circulation. 2007 May 1;115(17):2331-9. doi: 10.1161/CIRCULATIONAHA.106.676809. Epub 2007 Apr 16. Circulation. 2007. PMID: 17438150
534 results